2016-2017 Funded Collaborations
International Collaborative Grants
Developing Novel Therapeutic Approaches For High Risk Acute Lymphoblastic Leukemia
Hua E. Yu, Ph.D. |
Shai Izraeli, M.D. |
||
Characterization Of The Lung Cancer Microbiome And Its Effects On Response To Treatment
|
|||
Dan Raz, M.D. |
Ravid Straussman, M.D., Ph.D. |
||
Spectrum Of Germline P53 And Somatic Genomic Variants In Israeli Breast Cancer Patients
Jeffrey Weitzel, M.D. |
Gad Rennert, M.D., Ph.D. Carmel Medical Center, Community Medicine and Epidemiology |
||
WWOX Loss Activates Aerobic Glycolysis In TNBC
Victoria Seewaldt, M.D. |
Rami Aqeilan, Ph.D. |
||
Sabbatical
Distribution And Diffusion Of Nanoparticles In Tumoral Tissue
Jacob Berlin, Ph.D. |
Abraham Domb, Ph.D. |
||
About the Israel Cancer Research Fund Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org. |
|